Tag: Plenary Session 5
11 July 2021
Report: Plenary session 5 explores mHSPC treatments
The role of novel imaging and the treatment options for metastatic hormone-sensitive prostate cancer (mHSPC) were some of the topics
28 June 2021
Highlights in advanced prostate cancer
We interviewed Prof. Silke Gillessen Sommer (CH) who shared some of the EAU21 highlights to look forward to with regard